| Financial Year |
March 31 2023 |
| Monetary Funds |
168,010,167.55 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
59,046,751.94 |
| Advances to Suppliers |
1,043,351.62 |
| Other Receivables |
21,860,383.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
76,536,056.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
571,128.70 |
| Other Current Assets |
29,143,993.77 |
| Total Current Assets |
356,211,833.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
85,314.91 |
| Long-term Equity Investment |
369,119,903.41 |
| Investment Properties |
124,687,318.14 |
| Fixed Assetes |
326,948,647.51 |
| Under-construction Projects |
2,626,189.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
89,912,580.90 |
| R&D expenses |
-- |
| Goodwill |
3,441,520.15 |
| Long-Term Deferred and Prepaid Expenses |
63,046,682.94 |
| Deferred Income Tax Assets |
62,576,057.75 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,207,004,537.88 |
| Total Assets |
1,563,216,371.35 |
| Short-Term Loans |
30,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
163,968,718.22 |
| Accounts Received In Advance |
4,225,582.27 |
| Employee Compensation Payable |
55,080,903.24 |
| Taxes Payable |
5,438,326.41 |
| Interest Payable |
-- |
| Dividend Payable |
18,000.00 |
| Other payables |
166,464,523.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
70,765,028.44 |
| Other Current Liabilities |
5,557,045.79 |
| Sub-Total of Current Liabilities |
589,856,273.83 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
44,837,906.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
193,469,884.19 |
| Total Liabilities |
783,326,158.02 |
| Paid-In Capital(Or Share Stock) |
308,463,955.00 |
| Capital Surplus |
548,766,541.57 |
| Surplus Reserve |
155,893,906.63 |
| LESS:Treasury Stock |
15,369,025.40 |
| Undistributed Profits |
-239,358,832.95 |
| Minority Stockholder's Interest |
21,486,271.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
758,403,941.56 |
| Owner's Equity（Stockholder's Equity） |
779,890,213.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,563,216,371.35 |
